PixCell Medical announces FDA 510(k) clearance for HemoScreen Hematology Analyzer

Cumberland Pharmaceuticals signs definitive agreement to acquire VIBATIV from Theravance Biopharma

US FDA receives supplemental Biologics License Application for Seattle Genetics' Adcetris

US Food and Drug Administration approves Pfizer's Lorbrena

SpringWorks Therapeutics Receives FDA Orphan Drug Designation for MEK Inhibitor (PD-0325901) for the Treatment of Neurofibromatosis Type 1

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo in Combination with IPI-549 in Urothelial Cancer

US FDA Approves Lorbrena for Previously-Treated ALK-Positive Metastatic NSCLC

Aimmune Therapeutics Names Haumann to Board of Directors

European Commission grants approval to AbbVie's and Roche's combination of Venclyxto and MabThera

GW Pharmaceuticals launches EPIDIOLEX in US

FDA Approves US Merck's Keytruda in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

FDA Grants Breakthrough Therapy Designation for UroGen Pharma's UGN-101 for the Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

Pharm-Olam Conducts Pivotal Orphan Disease Trial, Leads to First Therapeutic Approved for the Treatment for Acquired Thrombotic Thrombocytopenic Purpura

Eagle Pharmaceuticals Touts Results of Study for Fulvestrant

Heron files HTX-011's NDA with US FDA for postoperative pain management